Delivery Order SPE2DB24D1205-SPE2DB25FCSXK

Award Date 1/8/25
Potential Completion Date 1/30/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, provides for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication, to the Defense Logistics Agency (DLA). The $16,561.26 firm-fixed-price delivery order has an ultimate completion date of August 12, 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $80,516.55, is for the delivery of DARZALEX FASPRO 1,800mg-30,000 15ml, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 13, 2023. This award does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $34,267.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, valued at $110,408.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a specialty medication, and is a Firm Fixed Price Delivery Order that runs through November 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,122.52, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $57,112.20 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024. The contract is a firm fixed-price Delivery Order with a completion date of January 10, 2025. This award is likely part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $82,685.76, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 6, 2022 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,920.84, is for the delivery order of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. It is a firm fixed-price contract with a completion date of February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $110,408.40 firm fixed-price delivery order is for the supply of DARZALEX FASPRO, a specialty medication, with a completion date of December 3, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $16,561.26 firm fixed price delivery order is for DARZALEX FASPR 1800 1S pharmaceutical products and related medical supplies. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSXK
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $17,940.63, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract provides for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, to support military healthcare programs. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the contract is a Firm Fixed Price arrangement.

Generated 4/9/25, 9:57 AM